Alerta De Seguridad para Defibrillator - Implantable Cardioverter ATLAS II AND EPIC II

Según National Institute of Drugs and Food Surveillance (INVIMA), este evento ( alerta de seguridad ) involucró a un dispositivo médico en Colombia que fue producido por St. Jude Medical Ab || St Jude Medical || St. Jude Medical Operations Sdn Bhd || St. Jude Medical. Cardiac Rhythm Management Division.

¿Qué es esto?

Las alertas proporcionan información importante y recomendaciones sobre los productos. Aunque se haya emitido una alerta, esto no significa necesariamente que el producto se considera peligroso. Las alertas de seguridad, dirigidas a trabajadores de la salud y a usuarios, pueden incluir retiro de equipos. Pueden ser escritas por los fabricantes, pero también por funcionarios del área de salud.

Más información acerca de la data acá
  • Tipo de evento
    Safety alert
  • ID del evento
  • Número del evento
  • Fecha
  • País del evento
  • Fuente del evento
  • URL de la fuente del evento
  • Notas / Alertas
    Colombian data is current through June 2019. All of the data comes from the National Institute of Drugs and Food Surveillance (INVIMA), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Colombia.
  • Notas adicionales en la data
  • Causa
    The manufacturer through routine electrical tests has identified faults originating in the manufacturing process, by assembling slightly larger vibrators that could damage the insulation coating of the high voltage capacitor, which would cause a narrowing of the distance between the two adjacent components, resulting in possible leakage of electrical current or an electric arc between the high-voltage capacitor and these components, leading to the occurrence of potential adverse events on patients.


  • Modelo / Serial
    CD1377-36C, CD1377-36QC, CD2377-36C and CD2377-36QC
  • Descripción del producto
    Designed to administer ventricular antitachycardia and ventricular defibrillation for the automatic treatment of ventricular arrhythmias that endanger the life of the patient. Addition of indication: indication for magnetic resonance imaging, for MRI cardioid defibrillators models CD2377-36Q, CD2377-36QC, CD1377-36Q, CD1377-36QC and QUADRAASSURA cardioid defibrillators models CD3367-40QC, CD3367-40Q and QUADRAASSURA MP models CD3371-40QC, CD3371- 40Q. The cardiofibrillators FORTIFY ASSURA DR models CD2359-40Q, CD2359- CD2359-40QC, and FORTIFY ASSURAVR models CD1359-40Q, CD1359-40QC; they are conditional to magnetic resonance, the use of these devices conditionally safe in the MRI environment if a conditional DAI system is used to complete MRI.
  • Manufacturer


  • Empresa matriz del fabricante (2017)
  • Comentario del fabricante
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source